Cryofocus 2025 Revenue Surges 78%, Losses Narrow by 60% as the Cryotherapy Leader Accelerates Commercialization

HONG KONG, Mar 30, 2026 – (ACN Newswire) – Cryofocus Medtech (Shanghai) Co., Ltd. (“Cryofocus” or the “Company”, Stock Code: 6922.HK), an innovative medical device platform company with a main focus on the field of minimally-invasive interventional cryotherapy,  recently announced its annual results for the year ended December 31…
Read More

Zaļā Josta - Reklāma